Literature DB >> 19212309

Characteristics of liver diseases in the elderly: a review.

A Premoli1, E Paschetta, M Hvalryg, M Spandre, S Bo, M Durazzo.   

Abstract

Chronic liver diseases are becoming more commonly diagnosed in the elderly, although they are not age-related. Most liver functions in advanced age appear to be well preserved, but some changes in liver morphology and physiology with aging may lead to several differences in clinical course and management of liver diseases in older patients compared to younger. A cautious individual evaluation is therefore required in aged patients, especially concerning reduced hepatic drug clearance and comorbidity. Many chronic liver diseases are characterized by a slow and indolent course with non-specific clinical presentation and this may lead a later diagnosis in the elderly. The presence of an advanced liver disease or cirrhosis is more frequent in old patients as the first clinical presentation. No significant differences in diagnostic investigations or treatment options occur between the elderly and the young. Hepatocellular carcinoma is an affliction of the old patients (mean age 65 age) and follow up with ultrasonography and alpha-fetoprotein is mandatory. Advanced age is not considered a contraindication to liver transplantation, but recipients older than 60 years with poor hepatic synthetic function and comorbidity show a worse prognosis with lower survival rates. This review focuses on new emerging conditions, clinical features and updated therapeutic approaches of the most common chronic liver diseases among the elderly.

Entities:  

Mesh:

Year:  2009        PMID: 19212309

Source DB:  PubMed          Journal:  Minerva Gastroenterol Dietol        ISSN: 1121-421X


  13 in total

1.  Global gene expression profile of normal and regenerating liver in young and old mice.

Authors:  Monica Pibiri; Pia Sulas; Vera Piera Leoni; Andrea Perra; Marta Anna Kowalik; Angela Cordella; Pasquale Saggese; Giovanni Nassa; Maria Ravo
Journal:  Age (Dordr)       Date:  2015-06-03

2.  Noninvasive Assessment of Liver Fibrosis By Transient Elastography and FIB4/APRI for Prediction of Treatment Response in Chronic Hepatitis C-An Experience from a Tertiary Care Hospital.

Authors:  Sunil Taneja; Sunil Tohra; Ajay Duseja; Radha Krishan Dhiman; Yogesh Kumar Chawla
Journal:  J Clin Exp Hepatol       Date:  2016-08-18

Review 3.  Nonalcoholic fatty liver disease and aging: epidemiology to management.

Authors:  Marco Bertolotti; Amedeo Lonardo; Chiara Mussi; Enrica Baldelli; Elisa Pellegrini; Stefano Ballestri; Dante Romagnoli; Paola Loria
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

4.  Activin A, p15INK4b signaling, and cell competition promote stem/progenitor cell repopulation of livers in aging rats.

Authors:  Anuradha Menthena; Christoph I Koehler; Jaswinderpal S Sandhu; Mladen I Yovchev; Ethel Hurston; David A Shafritz; Michael Oertel
Journal:  Gastroenterology       Date:  2010-12-11       Impact factor: 22.682

5.  Liver cirrhosis in elderly patients: clinical characteristics, complications, and survival-analyses from a large retrospective study.

Authors:  Naim Abu-Freha; Asia Estis-Deaton; Muhammad Aasla; Ohad Etzion; Aerin Philip; David Yardeni; Muhammad Abo Abed; Muhammad Abu Tailakh
Journal:  Aging Clin Exp Res       Date:  2022-06-07       Impact factor: 4.481

Review 6.  Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases.

Authors:  Carlotta Giorgi; Saverio Marchi; Ines C M Simoes; Ziyu Ren; Giampaolo Morciano; Mariasole Perrone; Paulina Patalas-Krawczyk; Sabine Borchard; Paulina Jędrak; Karolina Pierzynowska; Jędrzej Szymański; David Q Wang; Piero Portincasa; Grzegorz Węgrzyn; Hans Zischka; Pawel Dobrzyn; Massimo Bonora; Jerzy Duszynski; Alessandro Rimessi; Agnieszka Karkucinska-Wieckowska; Agnieszka Dobrzyn; Gyorgy Szabadkai; Barbara Zavan; Paulo J Oliveira; Vilma A Sardao; Paolo Pinton; Mariusz R Wieckowski
Journal:  Int Rev Cell Mol Biol       Date:  2018-06-22       Impact factor: 6.813

7.  Loss of GPR109A/HCAR2 induces aging-associated hepatic steatosis.

Authors:  Ravirajsinh N Jadeja; Malita A Jones; Ollya Fromal; Folami L Powell; Sandeep Khurana; Nagendra Singh; Pamela M Martin
Journal:  Aging (Albany NY)       Date:  2019-01-18       Impact factor: 5.682

Review 8.  Aging-Related Molecular Pathways in Chronic Cholestatic Conditions.

Authors:  Claudio Pinto; Elisabetta Ninfole; Antonio Benedetti; Luca Maroni; Marco Marzioni
Journal:  Front Med (Lausanne)       Date:  2020-01-21

9.  Impact of diabetes mellitus and chronic liver disease on the incidence of dementia and all-cause mortality among patients with dementia.

Authors:  Hyun Min Kim; Yong-Ho Lee; Kyungdo Han; Byung-Wan Lee; Eun Seok Kang; Jaetaek Kim; Bong-Soo Cha
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

Review 10.  Characteristic Features of Nonalcoholic Fatty Liver Disease in Japan with a Focus on the Roles of Age, Sex and Body Mass Index.

Authors:  Maki Tobari; Etsuko Hashimoto
Journal:  Gut Liver       Date:  2020-09-15       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.